A study of the time course of conversion of edematous to hemorrhagic pancreatitis.
We studied the conversion of acute edematous pancreatitis (AEP) to acute hemorrhagic pancreatitis (AHP) in an experimental model in cats. In the model, 16,16 dimethyl PgE2 effects this conversion by increasing microvascular permeability. First, we induced AEP in cats and then gave PgE2 at increasing intervals after the induction of AEP to see how long an interval would still allow conversion. In 6 groups of cats, PgE2 was administered for 2 h, starting at 2, 4, 6, 8, 10, or 12 h after the creation of AEP. Twelve h later, the cats were sacrificed and the pancreases were graded for inflammation and hemorrhage. Significant pancreatic hemorrhage did not occur when the PgE2 was administered at 12 h compared to 2 h. Next, we determined that PgE2 still retained its ability to increase pancreatic vascular permeability when administered 12 h after the creation of AEP. This was done by perfusing a marker molecule through the MPD (fluorescein isothiocyanate labeled dextran: FITC-D, mol wt 20,000) and then finding it in portal venous blood (PVB). The presence of FITC-D in PVB signified increased vascular permeability, since normally none was present. We concluded that conversion of AEP to AHP was possible during the first 12 h after induction of AEP. Lack of conversion at 12 h was not caused by a lack of vascular reactivity at that time.
Karanjia
N D
ND
Department of Surgery, VA Medical Center, Sepulveda, CA.
Singh
S M
SM
Porter-Fink
V
V
Widdison
A L
AL
Reber
H A
HA
D015064:16,16-Dimethylprostaglandin E2 / Q000008:administration & dosage; D000208:Acute Disease; D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects; D002415:Cats; D004195:Disease Models, Animal; D004487:Edema / Q000209:etiology / Q000473:pathology; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000473:pathology; D010189:Pancreatic Juice / Q000201:enzymology; D010195:Pancreatitis / Q000209:etiology* / Q000473:pathology; D013997:Time Factors
D015064:16,16-Dimethylprostaglandin E2